|
Contents
|
|
|
|
Cancer
Research |
|
|
|
|
Sarit Assouline
and Wilson
H. Miller
High-dose vitamin C therapy: Renewed hope or
false promise?
CMAJ, March 28, 2006; 174 (7).
.JPG)
Abstract | .png)
Full Text | .png)
Reprint
|
|
Cameron E, Pauling L
Supplemental
ascorbate in the supportive treatment of cancer: reevaluation of prolongation of
survival times in terminal human cancer
Proc Natl
Acad Sci U S A 1978 Sep;75(9):4538-42 (PDF Full
Text)
|
|
Cameron E, Pauling L
Supplemental
ascorbate in the supportive treatment of cancer: Prolongation of survival times
in terminal human cancer
Proc Natl
Acad Sci U S A 1976 Oct;73(10):3685-9 (PDF Full
Text)
|
|
Creagan
ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S
Failure
of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced
cancer. A controlled trial
N
Engl J Med 1979 Sep 27;301(13):687-90
|
|
|
Sebastian J. Padayatty, Hugh
D. Riordan, Stephen M. Hewitt, Arie Katz, L.
John Hoffer and Mark Levine
Intravenously administered vitamin C as
cancer therapy: three cases
CMAJ, March 28, 2006; 174 (7)
Abstract
|
Full Text |
Reprint
| .gif)
News
News
News
|
|
|
Glioblastoma |
|
|
|
|
Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL,
Krishna MC, Khosh DB, Drisko J, Levine M.
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth
of aggressive tumor xenografts in mice
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11105-9; Epub 2008 Aug 4
Abstract
|
|
|
Frei B, Lawson S.
Vitamin C and cancer revisited
Proc
Natl Acad Sci U S A. 2008 Aug 12;105(32):11037-8.
Epub 2008 Aug 5
Abstract |
Reprint
|
|
|
|
